Evidence map›Paper›PMID 36153428›Full record

ArticleScientific reports2022

Energy-efficient production of vaccine protein against porcine edema disease from transgenic lettuce (Lactuca sativa L.).

Asuka Yokoyama, Seika Oiwa, Takeshi Matsui, Kazutoshi Sawada, Yasushi Tasaka, Takeshi Matsumura

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Asuka YokoyamaInnovation Strategy and Carbon Neutral Transformation Department, Idemitsu Kosan Co., Ltd., 1-2-1, Otemachi, Chiyoda-Ku, Tokyo, Japan. asuka.yokoyama.4790@idemitsu.com.
Seika OiwaAdvanced Technology Research Laboratories, Idemitsu Kosan Co., Ltd., 1280 Kamiizumi, Sodegaura-Shi, Chiba, 299-0293, Japan.
Takeshi MatsuiAdvanced Technology Research Laboratories, Idemitsu Kosan Co., Ltd., 1280 Kamiizumi, Sodegaura-Shi, Chiba, 299-0293, Japan.
Kazutoshi SawadaAdvanced Technology Research Laboratories, Idemitsu Kosan Co., Ltd., 1280 Kamiizumi, Sodegaura-Shi, Chiba, 299-0293, Japan.
Yasushi TasakaBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Sapporo, Hokkaido, 062-8517, Japan.
Takeshi MatsumuraBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Sapporo, Hokkaido, 062-8517, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of functional protein production systems using transgenic plants as hosts has been rapidly progressing in recent years. Lettuce (Lactuca sativa L.) has been studied as one such host, and it has been reported that the biomass of lettuce per area and target protein expression level can be increased by optimizing the cultivation conditions. Therefore, we investigated methods to minimize the input light energy per target protein to reduce production costs. Herein, we examined the yield of a nontoxic B subunit of Stx2e (Stx2eB) from transgenic lettuce under various cultivation conditions. Stx2eB acts as a vaccine against swine edema disease. The effects of photon flux densities (PPFDs), photoperiod, and light source on Stx2eB production were examined and the findings suggested that 400 μmol m

Indexed as

Edema Disease of SwineAnimalsEdemaLactucaPhotoperiodPlants, Genetically ModifiedSwine

Identifiers

PMID36153428
PMCPMC9509315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.